跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 163 条关于
“HLHS”
全部
163
临床试验
96
药物
4
机构
1
资讯
62
去年
Longeveron Appoints Than Powell as Chief Business Officer to Lead Alzheimer's and HLHS Program Strategy
去年
Longeveron's Lomecel-B Shows Promising 5-Year Transplant-Free Survival in HLHS Patients
去年
Longeveron's Lomecel-B Nears Full Enrollment in Pivotal HLHS Trial, Shows Promise in Pediatric Heart Disease
去年
Longeveron's Lomecel-B Shows Long-Term Survival Benefit in HLHS Patients
2年前
Longeveron Achieves FDA Alignment on Lomecel-B Pathway for Hypoplastic Left Heart Syndrome
去年
Longeveron's Lomecel-B Shows Long-Term Survival Benefit in HLHS Patients
去年
Longeveron's Lomecel-B Shows Promise in HLHS and Alzheimer's Disease Trials
7年前
FDA Grants RMAT Designation To Mesoblast's Revascor for Pediatric Hypoplastic Left Heart Syndrome
前天
Longeveron's Laromestrocel Misses Primary Endpoint in ELPIS II Phase 2b Trial in Hypoplastic Left Heart Syndrome
去年
Longeveron's Lomecel-B Data in Alzheimer's Disease to be Presented at CTAD24
第 1 页,共 7 页
上一页
下一页